4D pharma to Participate at the Chardan Metagenomics and Mic

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced

Related Keywords

United States , Julie Seidel , Alex Stevenson , Duncan Peyton , Lynne Dardanell , Dominic Wilson , Philip Davies James Fischer , Chardan Metagenomics , Neil Hunter Michelle Boxall , Merck Co Inc , Bryan Garnier Co , Image Box Communications , Nasdaq , Chief Executive Officer , Chief Scientific Officer , Microbiome Medicines Summit , Capital Markets Nominated Adviser , Joint Broker , Davies James Fischer , Corporate Finance , Corporate Broking , Hunter Michelle Boxall , Pharma , Articipate , Chardan , Metagenomics , Icrobiome , Medicines , Summit ,